ECRM_1170x120_8-1-17

Lamar Alexander

Former Lilly exec Alex Azar tabbed to head HHS

Former Lilly exec Alex Azar tabbed to head HHS

WASHINGTON — Biopharmaceutical industry executive Alex Azar has been nominated as secretary of the U.S. Department of Health and Human Services (HHS) to fill the post vacated by Tom Price. Azar is currently founder and chairman of Seraphim Strategies LLC, an Indianapolis-based consultancy focused on the biopharma and health insurance industries, including biopharmaceutical sales, marketing, pricing,

Affordable Care Act still plagued by uncertainty

Affordable Care Act still plagued by uncertainty

WASHINGTON — The failed effort to overturn the Affordable Care Act has hardly erased doubts about the law’s short- and long-term viability. Already, the Trump administration has suspended contracts with two companies that have helped thousands of people in nearly a score of cities get health insurance under the statute. In ending the $22 million

Scott Gottlieb takes reins as FDA commissioner

Scott Gottlieb takes reins as FDA commissioner

WASHINGTON — Dr. Scott Gottlieb has been sworn in as the new commissioner of the Food and Drug Administration. Gottlieb, nominated as FDA commissioner by President Donald Trump in March, took the helm as the FDA’s 23rd commissioner on Thursday after being confirmed by a vote of 57-42 in the Senate late Tuesday. He takes